• Regulatory NewsRegulatory News

    Congressmen Investigate 'Shadow Pricing' of MS Drugs

    Democratic Reps. Elijah E. Cummings (MD) and Peter Welch (VT) on Thursday sent letters to seven pharmaceutical companies requesting information about the skyrocketing prices for drugs used to treat multiple sclerosis (MS). Cummings and Welch cited an  American Academy of Neurology study  finding that some companies appear to be increasing their prices when competitors do the same, a practice known as "shadow pricing." The study reported that annual MS drug sale...